Xanodyne Pharmaceuticals Company Description
Xanodyne Pharmaceuticals hopes that its medicines can be the X factor needed to treat ailments. The company develops and manufactures drugs for pain management and women's health. Its commercial offerings include pain treatments Darvocet, Roxicodone, and Oramorph SR, as well as Duet prenatal vitamins. Xanodyne has several drugs in late-stage development, including Zipsor, a treatment for mild to moderate inflammatory pain such as arthritic pain. Other candidates include a treatment for menorrhagia (excessive menstrual bleeding). The company funds its development efforts through sales of its commercial products, which are marketed through an internal sales force.
View the Comprehensive Company Description for Xanodyne Pharmaceuticals
The Company Description provides a historical perspective of Xanodyne Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Xanodyne Pharmaceuticals's evolution in the marketplace.
